GT Medical Technologies Wins Prestigious Innovator of the Year Award at the 2021 Governor's Celebration of Innovation
ncarol.com/10140205

PHOENIX - ncarol.com -- GT Medical Technologies, Inc. today announced it was named a winner of the Innovator of the Year in the small company category at the 2021 Governor's Celebration of Innovation, presented live on stage by the Arizona Technology Council and the Arizona Commerce Authority on October 13. GT Medical Technologies received this accolade in recognition of GammaTile^® Therapy, its Surgically Targeted Radiation Therapy (STaRT), developed to prevent or significantly delay the recurrence of operable brain tumors.

"We are honored to receive recognition for this innovative technology that overcomes the limitations of current brain tumor radiation treatments, raises the standard of care, and improves quality of life," said Matthew E. Likens, president, and CEO of GT Medical Technologies, Inc. "Since beginning full market release of GammaTile Therapy in the U.S. in March, 2020, over 50 major brain tumor treatment centers have adopted GT with many more in the pipeline. There have been few improvements in outcomes for these patients over the last 15 years so GT represents a major step forward."

More on ncarol.com

• Boston Corporate Coach™ Sets Global Standard for Executive Chauffeur Services Across 680 Cities
• UK Financial Ltd Announces CoinMarketCap Supply Verification And Market Positioning Review For Regulated Security Tokens SMPRA And SMCAT
• Sharpe Automotive Redefines Local Car Care with "Transparency-First" Service Model in Santee
• 14 Years of Sparking Curiosity in Out-of-School Time: From Empowering Gen Z to Nurturing Gen Alpha
• Secondesk Launches Powerful AI Tutor That Speaks 20+ Languages

Arizona's finest business leaders celebrate the state's technology innovation and leadership during GCOI. GT Medical Technologies was selected by judges for the company's numerous achievements, including  FDA 510(k) regulatory clearance for the treatment of all types of recurrent brain tumors and newly-diagnosed malignant tumors, and multicenter, randomized controlled trials such as one led by The University of Texas MD Anderson Cancer Center.

"We live in a world filled with innovative medical technology that is helping us take care of ourselves and improve our longevity," said Steven G. Zylstra, president and CEO of the Arizona Technology Council. "GT Medical Technologies is an example of an outstanding company based in Arizona that is contributing tremendous value to the MedTech industry. We congratulate the leadership and entire team for winning this well-deserved award."

About GT Medical Technologies, Inc.

More on ncarol.com

• Automation, innovation in healthcare processes featured at international conference in Atlanta
• A High-Velocity Growth Story Emerges in Marine and Luxury Markets
• $26 Billion Global Market by 2035 for Digital Assets Opens Major Potential for Currency Tech Company with ATM Expansion and Deployment Plans Underway
• 1300+ Small Business Leaders Sign Letter to Congress Urging Prompt Action to Protect US Innovation
• Peernovation 365 is Now Available

Driven to overcome the limitations of current treatments for brain tumors and raise the standard of care, a team of brain tumor specialists joined forces and formed GT Medical Technologies with the purpose of improving the lives of patients with brain tumors. GammaTile is available in top brain tumor centers across the United States. For more information or to find a GammaTile center near you, visit https://www.gtmedtech.com/ and follow @GTMedTech on Twitter and LinkedIn.